Endothelial nitric oxide synthase is strongly expressed in malignant mesothelioma but does not associate with vascular density or the expression of VEGF, FLK1 or FLT1

This publication has 31 references indexed in Scilit:

• A Novel Function of VEGF Receptor-2 (KDR): Rapid Release of Nitric Oxide in Response to VEGF-A Stimulation in Endothelial Cells
  Biochemical and Biophysical Research Communications, 1999
• Vascular Endothelial Growth Factor Can Substitute for Macrophage Colony-Stimulating Factor in the Support of Osteoclastic Bone Resorption
  The Journal of Experimental Medicine, 1999
• VEGF-A Induces Expression of eNOS and iNOS in Endothelial Cells via VEGF Receptor-2 (KDR)
  Biochemical and Biophysical Research Communications, 1998
• Significant Correlation of Nitric Oxide Synthase Activity and p53 Gene Mutation in Stage I Lung Adenocarcinoma
  Japanese Journal of Cancer Research, 1998
• Nitric Oxide Synthase Activity in Human Lung Cancer
  Japanese Journal of Cancer Research, 1997
• Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells
  Nature Medicine, 1996
• Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor
  Biochemical and Biophysical Research Communications, 1992
• Molecular cloning and characterization of human endothelial nitric oxide synthase
  FEBS Letters, 1992
• The fms -Like Tyrosine Kinase, a Receptor for Vascular Endothelial Growth Factor
  Science, 1992
• Malignant Pleural Mesothelioma: Some Aspects of Epidemiology, Differential Diagnosis and Prognosis
  Pathology - Research and Practice, 1990